Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 02. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8934  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178676  
   
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.
Nanomedicine (Lond)
Narayan A, Leibrandt RC, Lee JS, Dall'Era MA, Whitson JM, Chandrasekar T, Braun A, Mossanen M, Li H, Lara PN Jr, Lam KS, Pan CX, Parikh M.
PMID: 42226594 [PubMed - as supplied by publisher]


Study adds new evidence on use of salvage focal therapy for radio-recurrent prostate cancer.
Cancer
Lawrence L.
PMID: 42226545 [PubMed - in process]


Impact of Absolute PSA Value and Relative PSA Response Rate on Overall Survival in Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors.
Int J Urol
Suzuki T, Fukuda T, Nishizaki K, Fukui K, Yoshioka S, Kaizuka Y, Nagasawa S, Togo Y, Motoki Y, Tanaka W, Ueda Y.
PMID: 42226505 [PubMed - in process]


Development and validation of a machine learning model for predicting distant metastasis in patients with renal cell carcinoma: a population-based study.
World J Surg Oncol
Cheng C, Peng X, Qiu R, Ma H, Gui M, Shi R.
PMID: 42226290 [PubMed - as supplied by publisher]


MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial.
Eur Urol Oncol
Boschheidgen M, Al-Monajjed R, Schlemmer HP, Krilaviciute A, Bonekamp D, Herkommer K, Jahnen M, Gschwend JE, Düx D, Wacker F, Makowski MR, Sauter A, Kuczyk MA, Harke N, Debus J, Grott C, Lakes J, Radtke JP, Arsov C, Seibold P, Hadaschik B, Giesel F, Kristiansen G, Benner A, Antoch G, Becker N, Kaaks R, Albers P, Schimmöller L.
PMID: 42225542 [PubMed - as supplied by publisher]


Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.
Semin Nucl Med
Sadeghpour S, Saidi B, Sahafi P, Maleki F, Ranjbar S, Ghorbani M, Ghadiri Hakim H, Aghaee A, Fanti S, Beheshti M, Askari E.
PMID: 42225513 [PubMed - as supplied by publisher]


Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
Lancet Oncol
DeWeese TL, Manzanera A, Sylvester J, Wheeler T, Schroeder T, Gejerman G, Chesnut G, Facelle TM, Garzotto MG, Pieczonka C, Gandhi NM, Sukin S, Liss MA, Tutrone R, Mehlhaff B, Savage SJ, Goody M, Vogt J, Rao S, Polanco MLS, Barone F, Nichols WG, Tak PP, PrTK03 study team.
PMID: 42225101 [PubMed - in process]


Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
JAMA Netw Open
Zhang W, Wu H, Wang L, Xu H, Lin T, Tan P, Zhang P, Zheng X.
PMID: 42223943 [PubMed - indexed for MEDLINE]


Robotic-assisted radical prostatectomy using the Toumai system: initial single-center experience in Morocco.
J Robot Surg
Et-Touzani R, Aoid I, Zemrag J, Tibari Y, Ej-Jennane A, Bouab A, Faik H, Labyad A, Laraqui L, Deffar N, Touzani A, Ouzzane A.
PMID: 42223781 [PubMed - indexed for MEDLINE]


Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity.
J Robot Surg
Zorzi F, Amodeo A, Moretto S, Ingels A, Crestani A, Di Gianfrancesco L, Giannarini G, Tulone G, Simonato FA, Liguori G, Panthier F, Pandolfo SD, Contieri R, Perdonà S, Simonato A, Porreca A, Pavan N, Claps F.
PMID: 42223755 [PubMed - indexed for MEDLINE]


Renal and Extramedullary Involvement Revealing Atypical Multiple Myeloma: A Case Report and a Literature Review.
Tunis Med
El Ati Z, Hadhri A, Dahmane R, Ayed A, Hadj Brahim M, Boukadida R, Zouaghi K, Jaballah L, Raies L.
PMID: 42223467 [PubMed - indexed for MEDLINE]


Artificial intelligence-assisted urine cytology based on the Paris System for Reporting Urothelial Carcinoma.
Cancer Cytopathol
Chen L, Cao X, Lu Z, Liu L, Sun M, Wu Y, Zhang W.
PMID: 42223163 [PubMed - indexed for MEDLINE]


Perioperative Apalutamide in High-Risk Localized Prostate Cancer.
N Engl J Med
Taplin ME, Gleave M, Shore ND, Lopez-Gitlitz A, Kretschmer A, Efstathiou E, Nguyen PL, Damião R, Kamoto T, Ross A, Briganti A, Hadaschik BA, Heidenreich A, Juárez Soto Á, Ye H, Gotto G, Rooney B, Tian SK, Wetherhold L, Miladinovic B, McCarthy SA, Evans CP, Kibel AS, PROTEUS Investigators.
PMID: 42223077 [PubMed - as supplied by publisher]


PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer.
N Engl J Med
Agarwal N, Matsubara N, Azad AA, Saad F, Mateo J, Jiang S, Ye D, Voog E, Shore ND, Çil T, Vulsteke C, Chung HJ, Zschäbitz S, Laird AD, Zhang X, Nandoskar P, Chetcuti SF, Wang F, Fizazi K.
PMID: 42223064 [PubMed - as supplied by publisher]


Uncontrolled Hypertension Leading to the Diagnosis of Renal Cell Carcinoma: A Case Report.
Cureus
Loja J, Nascimento RF, Caldeira E, Moniz ME, Freitas JM.
PMID: 42222619 [PubMed]


Characteristics, treatment patterns, and outcomes of patients with metastatic prostate cancer during 2014-2022 in Pirkanmaa, Finland-an observational study.
Ther Adv Urol
Moisander M, Hölsä O, Teittinen K, Kysenius K, Kosunen M, Lehmus L, Murtola TJ.
PMID: 42221687 [PubMed]


[Expression of NF-κB, EGFR, and HER3 in castration-resistant prostate adenocarcinoma: a clinical and molecular study of 88 Moroccan patients].
Pan Afr Med J
Sadaoui I, Sadaoui I, Joutei HAH, Benomar H, Nadifi S.
PMID: 42221598 [PubMed - indexed for MEDLINE]


Radiological Presentations of Prostatic Carcinoma Patients: A Retrospective Observational Study From a Tertiary Care Oncology Setup.
Cureus
Altaf MO, Nasir K, Mughal Z, Niaz MM.
PMID: 42220745 [PubMed]


Efficacy and safety of immune checkpoint inhibitors combined with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: a risk-stratified systematic review and meta-analysis.
Front Immunol
Rao Y, Zhang J, Gu X, Han J, Ye Z.
PMID: 42220544 [PubMed - indexed for MEDLINE]


Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes.
Front Immunol
Chen ST, Zhou DR, Ge YJ, Chang L, Guo SH, Wu GS, Feng NH.
PMID: 42220493 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 178676    Seite 1 von 8934  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1